Mass Innovation Labs targets smaller startups — Boston Globe

The Boston Globe explored how we evolved our platform to serve smaller, highly focused research teams. The article highlights our decision to offer short-term, fully managed lab suites that matched the needs of early-stage biotech — flexible, compliant, and immediately operational.

This was a pivotal move that opened high-quality scientific infrastructure to first-time founders, academic spinouts, and seed-stage therapeutics startups. It also laid the foundation for the modular architecture that later became the Universal Lab Framework.

Read the full article → Boston Globe